Here are the 10-Q quarterly reports from Pacific Hlth CRE Orgz Inc (PFHO) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow PFHO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PFHO filings page.
Pacific Health Care Organization, Inc. (PFHO) reported third-quarter revenue of $1,512,564, down 5% from $1,586,984 a year earlier, while net income rose 50% to $334,610 from $223,002. Other income included $202,657 of employee retention credit refunds; operating income fell 34% to $134,334. The company provides workers’ compensation cost-containment services, principally to California employers and claims administrators.
For the nine months ended September 30, 2026, revenue declined 7% to $4,784,919, net income fell 26% to $855,287, and operating income decreased 18% to $676,415. Customer terminations reduced HCO and MPN revenue, while medical bill review and utilization review revenue rose 17% and 12%. Three major customers accounted for approximately 53% of sales, compared with two customers and 34% in the nine months ended September 30, 2025. ERC refunds totaled $239,970, including $37,313 of interest, and other income, net decreased 33%. Cash from operations was $730,169; management believes cash on hand and anticipated operating cash flows will be sufficient to fund operations for at least the next twelve months.
Pacific Health Care Organization generated revenue of $1.77 million for the three months ended June 30, 2026, up 3% year over year, and $3.27 million for the six‑month period, down 8%. For six months, HCO revenue fell 40% and MPN revenue 9% after a significant customer completed a phase‑out, while medical bill review and utilization review grew 22% and 12%, respectively. Net income was $327,008 for the three‑month period and $520,677 for six months, a 44% decline from 2025, mainly because the prior year included $488,655 of Employee Retention Credit refunds in other income.
At June 30, 2026, total assets were $14.11 million, including $2.24 million in cash and $10.23 million of U.S. Treasury bills classified as held‑to‑maturity; the company carried no debt and stockholders’ equity was $13.60 million. Operating cash flow for six months was $222,793. Three major customers accounted for about 51% of sales, and three significant customer terminations are expected to materially reduce future revenue, though management anticipates partial offsets from expanded services for remaining customers and cost reductions. In July 2026 the company received an additional $239,970 of ERC refunds and believes existing liquidity will support operations for at least the next twelve months.
Pacific Health Care Organization, Inc. reported lower results for the three months ended March 31, 2026. Revenue was $1.50 million, down from $1.82 million a year earlier, mainly from a 62% drop in HCO revenue after a significant customer phased out services.
Net income fell to $193,669 from $292,663, though basic and diluted EPS held at $0.02 on an unchanged 12.8 million share base. Utilization review revenue grew 9%, and employee advocate work helped support medical case management.
The company remains debt-free and highly liquid, with $2.40 million in cash and $10.14 million in held-to-maturity U.S. Treasury bills as of March 31, 2026. Customer concentration is high: three customers provided 49% of sales and 58% of accounts receivable. Management believes existing cash and operating cash flows can fund operations for at least 12 months, while noting ongoing sensitivity to customer losses and economic conditions.
Pacific Health Care Organization (PFHO) reported Q3 2025 results. Revenue was $1,586,984 and net income was $223,002, or $0.02 per diluted share. Year to date, revenue reached $5,132,339 and net income was $1,152,572, or $0.09 per diluted share, reflecting stronger operations and one-time items.
Q3 growth came from higher medical case management revenue (up 40%) and utilization review (up 9%), offset by declines in HCO (down 25%) and Other revenue. For the first nine months, medical case management rose 53% as employee advocate services expanded. Other income was boosted by Employee Retention Credit refunds received of $488,655, recorded as $419,801 in other income and $68,854 in interest. The company ended the quarter with cash of $2,178,688, U.S. Treasury bill investments of $9,833,845, and stockholders’ equity of $12,839,775. Two customers accounted for 34% of nine‑month sales, highlighting concentration. As of November 4, 2025, shares outstanding were 12,800,000.